Gimbal Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$10.8M Sell
14,094
-3,066
-18% -$2.28M 6.46% 7
2025
Q2
$13.4M Sell
17,160
-835
-5% -$649K 8.22% 7
2025
Q1
$14.9M Sell
17,995
-133
-0.7% -$111K 13.41% 4
2024
Q4
$14M Hold
18,128
11.43% 3
2024
Q3
$16.2M Sell
18,128
-73
-0.4% -$65.6K 10.49% 4
2024
Q2
$17M Sell
18,201
-414
-2% -$331K 12.51% 3
2024
Q1
$14.5M Sell
18,615
-170
-0.9% -$121K 11.85% 3
2023
Q4
$11M Buy
+18,785
New +$11M 10.98% 5

Other funds holding LLY

Gimbal Financial's LLY Position: Q3 2025 in Review

Gimbal Financial reduced its Eli Lilly (LLY) stake by 18% in Q3 2025, selling an estimated $2.28M and leaving 14,094 shares worth $10.8M. The position accounts for 6.46% of the portfolio, ranked #7.

Gimbal Financial first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $17M in Q2 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Gimbal Financial held 14,094 shares of Eli Lilly worth $10.8M as of Q3 2025.
  • Gimbal Financial sold 3,066 Eli Lilly shares in Q3 2025, an estimated $2.28M.
  • Eli Lilly made up 6.46% of Gimbal Financial's portfolio in Q3 2025, its #7 holding.
  • Gimbal Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • Gimbal Financial's Eli Lilly position peaked at $17M in Q2 2024.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Gimbal Financial's 13F filing for Q3 2025, filed 4 Nov 2025.